# Leo Li

> Leo Li is a startup investor at Cenova. See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cenova](https://shizune.co/investors/profile/cenova-ventures)
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/leo-li-13628616a

Leo Li is a startup investor at Cenova. Mr. Li has extensive experience in financial and industrial analysis, auditing, and VC investment. He joined the firm in 2010, and has been taking roles of increasing responsibilities at Cenova. Currently he is mainly responsible for identifying, screening and evaluating new investment opportunities, especially deals in medical device andhealthcare service. Mr. Li is also actively involved in management of portfolio companies, including Chenguang Medical (SZ 430300), START Shanghai, Micropoint Bioscience, Aohua Endoscope and Fugao.Prior to Cenova, Mr. Li was an analyst at KTB investment group where he focused on investments in consumer, clean technology sectors and other late stage/growth capital opportunities. Before that, Mr. Li was with KPMG Shanghai office, providing internal and external audit services to various multinational corporations and Chinese state owned enterprises. Mr. Li also worked at Belmont Partners as a financial analyst.

## About Cenova

VC Fund · Shanghai, China

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

5 contacts available at Cenova.

| Name | Title | Profile |
| --- | --- | --- |
| Jun Wu | Founder and Chairman | https://shizune.co/investors/profile/jun-wu-3 |
| Kai Zhao | Managing Partner | https://shizune.co/investors/profile/kai-zhao-3 |
| Lehman Gu | Venture Partner | https://shizune.co/investors/profile/lehman-gu |
| Leo Li | Vice President | https://shizune.co/investors/profile/leo-li |
| Melissa Zhang | Vice President | https://shizune.co/investors/profile/melissa-zhang |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co